Rhenovia launches drug discovery programs in rare, orphan and neglected neurodegenerative diseases
Neurological specialist will carry out research based on its unique biosimulation platforms
21-Mar-2012 -
Rhenovia Pharma announced that it has initiated drug research programs in rare, orphan and neglected diseases.Rare diseases are defined as those affecting fewer than one in 2,000. Eighty per cent are caused by genetic defects but they also include rare forms of cancer, auto-immune disorders, ...
drug discovery
Duchenne muscular dystrophy
Huntington's disease
+1